Recent reports have sparked significant alarm regarding Wockhardt’s cough medication, specifically concerning the detection of unacceptable levels of dextromethorphan and potentially contaminants. Although the company previously maintained its adherence to safety, several cases of adverse health effects, including critical impairment and potentia